A180 100ML

Description

A180 100ML In cattle: Treatment of bovine respiratory illness caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinVM 42058/4000 A180 100ML

V (Canada)
Print ShareA180 100ML
(Canada)
This page contains information on for veterinary use.
The information provided typically includes the following:A180 100ML
Indications
Warnings and cautions for
Direction and dosage information for
A180
This treatment applies to the following species:
Beef Cattle

danofloxacin mesylate sterile injectable solution

Veterinary Use Only

Description
A180 Injectable Solution is a sterile solution containing danofloxacin mesylate, a synthetic fluoroquinolone antimicrobial agent. Danofloxacin mesylate is the non-proprietary designation

Figure 1. The chemical structure of danofloxacin mesylate

Each mL contains 180 mg of danofloxacin (as danofloxacin mesylate) and 2.5 mg phenol as the preservative.

A180 Indications
For the treatment of bovine respiratory disease associated with Mannheimia haemolytica and Pasteurella multocida.

Dosage and Administration
Care should be taken to dose accurately. Administered dose volume should not exceed 15 mL per injection site.

Single-Dose Therapy: Administer subcutaneously at 8 mg/kg of body weightas a one-time injection,

Multi-Day Therapy: Administer subcutaneously at 6 mg/kg of body weight with this treatment repeated once approximately 48 hours following the first injection

In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacin

In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacin

In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherich